ANN ALCAZAR: Open Payments
NPI 1598208068 · PITTSBURGH, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$932 in 36 payments from 9 companies in 2025. Trend: 2023 $112 · 2024 $563 · 2025 $932
Food & beverage: $821Education: $111
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 9 | $239 |
| Teva Pharmaceuticals USA, Inc. | 6 | $229 |
| Indivior Inc. | 6 | $153 |
| Otsuka America Pharmaceutical, Inc. | 5 | $101 |
| Vanda Pharmaceuticals Inc. | 4 | $93 |
| Alkermes, Inc. | 3 | $67 |
| E.R. Squibb & Sons, L.L.C. | 1 | $19 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
| Neurocrine BioSciences, Inc. | 1 | $15 |
Products named: BRIXADI, SUBLOCADE, ABILIFY MAINTENA, AUSTEDO XR, ARISTADA, FANAPT, HETLIOZ, COBENFY.
Industry payments across PA — which companies pay providers there.
